Risk of ocular neovascular conversion and systemic bleeding complications in patients with AMD on DOACs or Warfarin Macular Diseases Share: Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me Forgot password? Click here
Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me